I guess the last few days of selling culled the potential universe of names here. Of the names making the list, we an ETF (WETF) announcing a distribution and the stock of IDT, which caught a downgrade by a bulge bracket investment house. The last name is most interesting to me. CEMP was down significantly along with a host of other bio-tech names. However, I doubt that a stock would be down this much due to 'sector-related' trading. This looks like a story stock to me with relatively little value support. And you (I) would have to do some further research on the following comment, but the company sends up flags on my accounting manipulation screen.